CD34 and inflammatory myofibroblastic tumor: The main differential diagnosis of this LMNA-NTRK1 fusion tumor was IMT because of prominent inflammatory cells in the tumor, but it can be ruled out based on its immunoprofile (SMA-negative, with S100/CD34 coexpression).